Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide

Author： Hesselbjerg Louise Justesen  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.7, 2013-07, pp. : 845-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

By  

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 4, 2015-04 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review of economic evaluations and cost analyses of guideline implementation strategies

By Vale Luke   Thomas Ruth   MacLennan Graeme   Grimshaw Jeremy  

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 111-121

Springer Publishing Company

Access to resources Recommend Favorite

Are vitiligo treatments cost‐effective? A systematic review

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e57-e58

John Wiley & Sons Inc

Access to resources Recommend Favorite

De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections

By Masterton Robert G.   Casamayor Montserrat   Musingarimi Primrose   van Engen Anke   Zinck Raymund   Odufowora-Sita Olatunji   Odeyemi Isaac A. O.  

Journal of Medical Economics, Vol. 16, Iss. 11, 2013-11 ,pp. : 1344-1356

Informa Healthcare

Access to resources Recommend Favorite

Economic evaluations of homeopathy: a review

By Viksveen Petter   Dymitr Zofia   Simoens Steven  

The European Journal of Health Economics, Vol. 15, Iss. 2, 2014-03 ,pp. : 157-174

Springer Publishing Company

Access to resources Recommend Favorite